QuidelOrtho 

$13.97
91
+$0.04+0.29% Friday 20:00
+$0.00+0%Friday 20:04After hours

Statistics

Day High
13.97
Day Low
13.95
52W High
35.58
52W Low
9.92
Volume
28,028
Avg. Volume
-
Mkt Cap
958M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.05
0.23
0.52
0.8
Expected EPS
0.202338
Actual EPS
N/A

Financials

-41.45%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.73BRevenue
-1.13BNet Income

Analyst Ratings

14.88Average Price Target
The highest estimate is 18.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
75%
Sell
25%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QDEL. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories competes directly with QuidelOrtho in the diagnostics and medical device sector, particularly in rapid diagnostics and point-of-care testing.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation, through its subsidiaries, offers a range of diagnostic solutions and products that overlap with QuidelOrtho's offerings, including immunoassay and molecular diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories provides a variety of clinical diagnostics and life science research products that compete with QuidelOrtho's diagnostic solutions.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a broad range of diagnostics and research products that compete with QuidelOrtho, including in areas like clinical diagnostics and life sciences.
Resmed
RMD
Mkt Cap34.67B
ResMed Inc. competes with QuidelOrtho in the health sector, particularly in products related to sleep and respiratory disorders, though its direct competition is more niche.
Becton Dickinson
BDX
Mkt Cap51.62B
Becton, Dickinson and Company offers a wide range of medical devices and diagnostic products that compete with QuidelOrtho's offerings in diagnostics and medical devices.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America Holdings operates in the healthcare diagnostics sector, providing services and solutions that compete with QuidelOrtho's diagnostic products.
Quest Diagnostics
DGX
Mkt Cap26.79B
Quest Diagnostics Incorporated provides diagnostic testing, information, and services that compete with QuidelOrtho's diagnostic solutions and services.
Agilent Technologies
A
Mkt Cap43.38B
Agilent Technologies, Inc. competes with QuidelOrtho in the life sciences and diagnostics sectors, offering analytical instruments and services that overlap with QuidelOrtho's market.

About

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
Show more...
CEO
Brian J. Blaser
Employees
6500
Country
United States
ISIN
US2197981051
WKN
000A3DNGX

Listings

0 Comments

Share your thoughts

FAQ

What is QuidelOrtho stock price today?
The current price of QDEL is $13.97 USD — it has increased by +0.29% in the past 24 hours. Watch QuidelOrtho stock price performance more closely on the chart.
What is QuidelOrtho stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange QuidelOrtho stocks are traded under the ticker QDEL.
Is QuidelOrtho stock price growing?
QDEL stock has fallen by -5.22% compared to the previous week, the month change is a -20.15% fall, over the last year QuidelOrtho has showed a -51.29% decrease.
What is QuidelOrtho market cap?
Today QuidelOrtho has the market capitalization of 958M
When is the next QuidelOrtho earnings date?
QuidelOrtho is going to release the next earnings report on November 04, 2026.
What were QuidelOrtho earnings last quarter?
QDEL earnings for the last quarter are 0.13 USD per share, whereas the estimation was -0.05 USD resulting in a +366.16% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is QuidelOrtho revenue for the last year?
QuidelOrtho revenue for the last year amounts to 2.73B USD.
What is QuidelOrtho net income for the last year?
QDEL net income for the last year is -1.13B USD.
How many employees does QuidelOrtho have?
As of September 05, 2026, the company has 6,500 employees.
In which sector is QuidelOrtho located?
QuidelOrtho operates in the Health & Wellness sector.
When did QuidelOrtho complete a stock split?
QuidelOrtho has not had any recent stock splits.
Where is QuidelOrtho headquartered?
QuidelOrtho is headquartered in SAN DIEGO, United States.